ilumivu

Located in the United States, ilumivu is a health tech startup established in 2009, specializing in healthcare decision support and heart health monitoring. The company leverages the psychology of behavior change and real-time data from smartphones and wearables to provide just-in-time adaptive interventions for patients, enhancing measurable care outcomes. With a strong research background from over 100 leading research universities and health systems, ilumivu offers digital health SaaS software to monitor patients with various health conditions, including but not limited to autism, Alzheimer’s, cardiovascular diseases, cancer, mental and behavioral issues, and trauma/PTSD. In October 2021, ilumivu made a significant move by acquiring the heart health app Cardiogram, which had already gained traction since its establishment in 2016. Cardiogram has successfully trained a neural network using millions of cardiovascular data points to identify medical conditions such as atrial fibrillation, diabetes, hypertension, and sleep apnea. The acquisition marked a milestone for ilumivu and its expansion into heart health monitoring. Notably, the Cardiogram mobile app is compatible with various devices, including Apple iOS and Android smartphones, Apple Watch, WearOS by Google, Fitbit, Garmin, and Samsung wearables, with over 3.1 million downloads globally. The Series A investment in ilumivu took place on 21 October 2021 and was supported by Health Catalyst Capital and Pisgah Fund. This critical funding injection signifies the confidence of the investment community in ilumivu's innovative healthcare solutions, particularly in the realm of digital health and personalized patient care outcomes.